| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3feb9020d65377aeec3415e7b21e0b1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5ef7bd80d9456bdf43058e0b7642cfe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8ddbc001b6aa3acc8f5bf7a88719b9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59b676211713100bdc000bb07bd859af |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-123
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate |
2012-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34ffd20d09e62b28be2c0a775ffedc25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e09eafa7cfad5a1d4e7a03798dcd1c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ecb0f0565c8608c9e4f11db45587a07 |
| publicationDate |
2014-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8748391-B2 |
| titleOfInvention |
β-turn peptidomimetic cyclic compounds for treating dry eye |
| abstract |
The present invention relates to methods of treating dry eye using β-turn peptidomimetic cyclic compounds or derivatives thereof. The β-turn peptidomimetic cyclic compounds can be used alone, in combination and/or in conjunction with one or more other compounds, molecules or drugs that treat dry eye. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014274910-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9707267-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9156882-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017152027-A1 |
| priorityDate |
2008-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |